Kaida BioPharma Inc. research brief
CIK 1973954
Generated Nov. 17, 2026, 3:36 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: FORT LAUDERDALE Florida. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Sept. 1, 2026 · D/A · 0001493152-26-040893 · Source evidence
Reported offering amount: 4100507 USD. Reported amount sold: 1600507 USD.
- Jan. 21, 2026 · D · 0001493152-26-003028 · Source evidence
Reported offering amount: 3000000 USD. Reported amount sold: 1570507 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Kaida BioPharma Inc. research brief,” CIK 1973954, retrieved Nov. 17, 2026, 3:36 p.m.. Cite the specific accessions used. No amounts have been summed.